HKW has partnered with the Cherubini family to recapitalize AliMed Inc., enhancing its growth potential in the healthcare market.
Information on the Target
AliMed Inc. is a nationally recognized provider of branded medical products, based in Dedham, Massachusetts. Established in 1970, AliMed has built a robust customer base, serving over 15,000 acute and non-acute care facilities, which include hospitals, surgery centers, nursing homes, and long-term care facilities. The company's commitment to quality and service has sustained its growth over the decades, positioning it as a leader in medical supply solutions.
With a focus on creating flexible supply chain solutions, AliMed enhances clinician safety and empowers healthcare providers to foster positive patient experiences. Their broad range of high-quality medical products and devices addresses various needs across the healthcare spectrum.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in the Target’s Specific Country
The healthcare industry in the United States is one of the largest and fastest-growing sectors in the economy, fueled by an aging population, advancements in medical technology, and increasing demand for healthc
Similar Deals
Thesis Capital Partners → The Ridge Ohio
2025
Everberg Capital → Allied OMS
2025
NorthCoast → Comprehensive EyeCare Partners
2025
Aldrich Capital Partners → Persivia
2025
Wellspring Capital Management → Summit Spine & Joint Centers
2025
Perceptive Advisors, LLC → TELA Bio, Inc.
2025
HKW
invested in
AliMed Inc.
in 2025
in a Recapitalization deal